Genomic rearrangements of the MYB gene and mutations that create de-novo Myb binding sites in the transcriptional control region of the TAL1 oncogene have been detected in acute lymphoid leukemia [2–4]. The gene discussed is MYB; the disease is acute lymphoblastic leukemia.